<strike id="gegfc"><dl id="gegfc"></dl></strike>
<sub id="gegfc"></sub>

    <mark id="gegfc"></mark>

      China Focus: Artificial heart powered by China's aerospace technology to undergo clinical research

      Source: Xinhua| 2019-09-03 16:57:22|Editor: Shi Yinglun
      Video PlayerClose

      BEIJING, Sept. 3 (Xinhua) -- A Chinese artificial heart design used in patients with aerospace technology will go into clinical research by the end of this year, according to its developer. Once reaching the market, it may help millions of people in China suffering from weak hearts.

      Developed by scientists from the No. 18 Research Institute under the China Academy of Launch Vehicle Technology, the country's leading rocket maker, the artificial heart called HeartCon weighs only 180 grams and is smaller than the size of a fist.

      After being implanted into a human to replace the original heart organ, it will function as a pump that delivers blood to the whole body, said Xu Jian, chief engineer of the project.

      The artificial heart works similarly to a rocket's servomechanism, which is driven by a hydraulic pump, Xu said.

      A servomechanism is a device used to provide control of a desired operation through the use of feedback.

      "The servomechanism on a rocket has higher requirements in speed and power, while the artificial heart demands more focus on safety and comfort as it is small and needs to be implanted," Xu said.

      Scientists from the institute began developing the artificial heart in 2009. They used magnetic and fluid levitation, which are used in rocket servo technology, to produce an implantable third-generation ventricular assistive device, a mechanical pump to support heart function while causing less damage to patients' blood than previous types.

      The HeartCon was tested in many animal experiments. In 2013, a sheep with the implanted artificial heart lived for 120 days. Two years later, the hearts were placed in three sheep, and all survived, indicating that the device was ready for batch production.

      In 2017, scientists implanted the HeartCons into six sheep and set a new record as one of them survived for 180 days.

      The success was also achieved in humans. A 39-year-old male and a 62-year-old female were the first two patients implanted with HeartCons in March this year in Tianjin. Both of them are in good health.

      This is not the first Chinese artificial heart to save patients. In 2017, doctors from Beijing's Fuwai Hospital, China's leading hospital specializing in cardiovascular diseases, saved three patients with artificial hearts they developed.

      There are at least 10 million people in China with failing hearts, and the number is growing due to the aging population.

      Drugs have little effect, and heart transplants used to be the only solution. However, organ transplants are limited by a lack of donors, said Ren Wanfeng, a cardiovascular specialist at the Peking University Health Science Center.

      Many patients had to travel abroad to get an imported artificial heart, which cost as high as 100,000 U.S. dollars. According to researchers, the HeartCon will be cheaper, bringing benefits to more patients in China.

      The HeartCon is expected to be approved for sale within two years.

      TOP STORIES
      EDITOR’S CHOICE
      MOST VIEWED
      EXPLORE XINHUANET
      010020070750000000000000011100001383616831
      中文字幕日韩无线码在线一区_制服肉丝亚洲中文字幕_日韩欧美无砖专区一中文字目_国产精品点击进入在线影院高清
      <strike id="gegfc"><dl id="gegfc"></dl></strike>
      <sub id="gegfc"></sub>
      
      
        <mark id="gegfc"></mark>
          色老板精品视频在线观看 | 亚洲欧美久久精品电影 | 日韩国产精品vA一区二区 | 在线观看亚洲精品自拍 | 亚洲色大情久久久 | 小早川怜子国内精品久久久久 |